International Clinical Trial: Low-Dose Atropine Eye Drops for Excessive Tearing (Epiphora)

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816224) titled 'Low-Dose Atropine Eye Drops for Excessive Tearing (Epiphora)' on Sept. 7.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).

Primary Sponsor: Rehan Ahmed

Condition: Epiphora

Intervention: Drug: Atropine sulfate ophthalmic solution 0.005%

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: September 2026

Target Sample Size: 16

To know more, visit https://clinicaltrials.gov/study/NCT07816224

Published by HT Digital Content Services w...